๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Effectiveness of Osteopathy as an Adjunct to Optometric Vision Therapy in Vergence Disorders

RecruitingNAAges 18 Years - anyAllJordi Zaragoza
NCT07452679 on ClinicalTrials.gov โ†—
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Vergence disorders are common binocular vision conditions that can cause symptoms such as eyestrain, blurred vision, headaches, and difficulty maintaining clear vision during near tasks. These symptoms are particularly frequent in situations involving sustained near visual demand, such as prolonged use of digital devices, which is increasingly common in daily life. Optometric vision therapy is considered the reference treatment for vergence disorders. However, not all individuals respond in the same way, and some continue to experience symptoms despite appropriate treatment. For this reason, adjunct therapeutic approaches are being explored to improve clinical outcomes. The purpose of this study is to evaluate whether osteopathic manual therapy, when used as an adjunct to optometric vision therapy, provides additional benefits compared with vision therapy alone or vision therapy combin

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Adult workers (โ‰ฅ18 years) whose regular occupational duties involve screen-based work. * Presence of symptoms consistent with binocular vision dysfunction, defined as a Convergence Insufficiency Symptom Survey (CISS-V15) score โ‰ฅ21 at baseline screening. Exclusion Criteria: * Severe ocular disease or systemic conditions affecting vision (e.g., age-related macular degeneration, retinopathies, glaucoma, keratoconus). * Neurological disorders affecting ocular motility or visual function (e.g., multiple sclerosis; cranial nerve III, IV, V, or VI palsy). * Manifest ocular deviation not suitable for management with visual therapy. * Inadequate refractive correction or prism requirement \>10 prism diopters (\>10ฮ”). * Refractive surgery (LASIK/PRK), cataract surgery, or any ocular surgery likely to influence binocular vision within the past 6 months. * Use of medications known to affect ocular motility or accommodative function. * Cognitive impairment or neurological conditions interfering with adherence to therapy instructions. * Suppression or severe amblyopia limiting response to visual therapy. * Best-corrected visual acuity \<0.5 decimal (equivalent to worse than 20/40) at distance or near.
๐Ÿ’Š

What it tests

  • Optometric Vision Therapy
  • Osteopathic Manual Therapy
  • Sham Osteopathic Intervention
๐Ÿ“

Where

1 site
Jordi Zaragoza osteopatia
Andorra la Vella, Andorra
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy